Zobrazeno 1 - 10
of 138
pro vyhledávání: '"J.P. Bergerat"'
Autor:
J.P. Bergerat
Publikováno v:
Oncology Research and Treatment. 24:302-315
Autor:
H.J. Staab, W. Queisser, N. Harbeck, U. Meier, H. Stammberger, J. Hilfrich, G. Jessernigg, A. Krüger, P. Šlampa, J. Heymanns, R. Würstlein, J. Sehouli, C. Kolotas, A. Gugl, G.H.J. Mickisch, C. van Soest, A. Beham, P. Čoupek, G. Schackert, G. Fleckenstein, F. Wenz, W. Marbé, S. Sinz, R. Kuse, H. Köppler, S. Kopp, M. Scheer, R.E. Kates, C. Lohfert, N. Zamboglou, J.P. Bergerat, T.G. Wendt, J. Petera, S.B. Sobottka, M. Schmitt, A. Steinmetz, S. Kunert, M.E. Heim, H. Colberg, R. Weide, I. Özkan, S. Samel, H. Deertz, F. Jänicke, W. Wuttke, O. Kodalle, S. Filip, A.E. Schindler, S. Post, C. Oberhoff, C. Thomssen, B. Sattler, B. Hinney, R. Hofheinz, K.-H. Preisegger, R. Osmers, A.C. Kübler, J. Sturm, P. Kalmár, A. Hundt, P. Zatloukal, G. von Minckwitz, D.G. Kieback, Heidelberg P. Drings, M. Mesrogli, J.E. Zöller, M.R. Knoll, Wien H. Huber, R. Soumarová, G. Emons
Publikováno v:
Oncology Research and Treatment. 24:205-210
Autor:
M. Hentrich, B. Thürlimann, P.A. Diener, H.E. Schaefer, A. Laplace, H. Heimpel, H. Rübben, S. Dowden, G. Deplanque, C. Bokemeyer, T. Schnabel, W. Werner, L. Kanz, C.F. Hess, B. Duclos, P. Dufour, G.A. Nagel, J. Löffler, P. Lehmann, D. Shen, K. Junker, J.A. Deardorff, C.A. White, W. Hohenberger, U. Schumacher, M. Wannenmacher, M. Bischof, R. Hartenstein, H. Jäger, W. Ebert, B.K. Dallaire, R. Herbrecht, B. Lioure, H. Hebart, W. Golder, K.-H. Schöter, H. Einsele, C. Giron, A. Müller, D. Latz, M. Mannhart-Harms, J.E. Kurtz, T. Otto, J.M. Limacher, K. Metz, M.E. Scheulen, C. Varns, S. Kasimir-Bauer, J. Schubert, A.J. Grillo-Lopez, Z. Herrmann, C. Geis, H. Wunderlich, J.P. Bergerat, R. Urscheler, A. Bex
Publikováno v:
Oncology Research and Treatment. 22:177-182
Autor:
J.P. Bergerat, Brigitte Duclos, Patrick Dufour, G. Deplanque, Raoul Herbrecht, Bruno Lioure, Jean-Emmanuel Kurtz, Anne Laplace, Jean-Marc Limacher, Cathy Giron
Publikováno v:
Oncology Research and Treatment. 22:212-215
Summary Background: Advanced ovarian cancer is often a fatal disease, despite good initial response to chemotherapy. Dose-intense schedules have been reported, but faile
Publikováno v:
Médecine et Maladies Infectieuses. 23:658-662
Resume L'effet benefique de la decontamination digestive sur la reduction de l'incidence de la maladie du greffon contre l'hote (GvHD) est generalement admis. Nous rapportons ici notre experience portant sur 40 greffes allogeniques successives realis
Publikováno v:
DNA and Cell Biology. 12:415-423
Proteins of the complement system (C2, C3) are synthesized by human monocytes and macrophages, thus providing an important local source of these proteins in vivo which serve as a first-line host defense mechanism. In this study, we investigated the p
Autor:
Irène Asmane, Jean-Emmanuel Kurtz, Philippe Barthélémy, Carole Mathelin, Damien Heitz, H. Polesi, Lynn Rob, Valère Litique, J.P. Bergerat
Publikováno v:
Critical reviews in oncology/hematology. 79(2)
Elderly breast cancer (EBC) patients are often denied adjuvant chemotherapy because of age. Breast cancer is among the most frequent cancer in Western Countries and recent data suggest that adjuvant chemotherapy could be active in selected elderly pa
Publikováno v:
Pharmacy worldscience : PWS. 31(6)
Case description A French Caucasian man aged 39 with HIV infection was treated with abacavir/lamivudine and ritonavir/lopinavir. The patient (normal renal and liver functions) was diagnosed with a Burkitt lymphoma for which he was treated with cyclop
Publikováno v:
Journal of Immunological Methods. 143:209-221
In vitro differentiation of human monocytes (Mo) provides large amounts of mature and functionally competent macrophages (M phi) which may be used as potentially powerful anticancer agents for adoptive immunotherapy. Granulocyte macrophage-colony sti
Autor:
A. Faradji, A. Bohbot, M. Schmitt-Goguel, S. Dumont, A. Eischen, M.L. Wiesel, A. Stierle, G. Follea, M. Eber, J.P. Bergerat, J. Bartholeyns, P. Poindron, J.P. Witz, H. Frost, F. Oberling
Publikováno v:
The International Journal of Artificial Organs. 14:304-312
Human blood monocytes (Mo) and monocyte-derived macrophages (MØ) are known to be potent antitumor cytotoxic effector cells through activation with recombinant human interferon gamma (rIFN-y), bacterial muramyldipeptide or the synthetic derivative mu